News search

    E.g., 05/06/2024
    E.g., 05/06/2024
    Atrial electroanatomic map of a pig with persistent AFib. The regions colored magenta, purple, and dark blue have high mean FM values. These regions maintain the AFib, and their ablation with a catheter stops the arrhythmia. The squares represent the sites of rotational activity, which are sensitive but not specific to the regions that maintain the fibrillation.
    Research
    12 Sep 2019
    Circulation Research: A new method to improve treatment of atrial fibrillation

    The new study was conducted by investigators at the CNIC, the Hospital Clínico San Carlos in Madrid, and the CiberCV research network and is featured on the cover of the latest edition of the journal Circulation Research

    Pilar Gonzalo, Rosa Nevado, Ricardo Villa-Bellosta, Magda R. Hamczyk, María J. Andrés-Manzano, and Vicente Andrés.
    Research
    12 Mar 2019
    EMBO Molecular Medicine: CNIC scientists discover a new therapeutic target for blocking early atherosclerosis in progeria

    This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease
    Research
    16 Nov 2018
    Nature Communications: Blocking hypertension with antihypertensive drugs prevents the development of a lethal disease

    The study results, published in the journal Nature Communications, identify several proteins implicated in this disease
    Foto
    Research
    5 Mar 2018
    Circulation: Scientists Discover the Cause of Accelerated Atherosclerosis and Premature Death in Progeria

    Investigadores del CNIC, del CIBERCV y de la Universidad de Oviedo han creado el primer modelo de ratón con aterosclerosis acelerada por la proteína progerina
    About the CNIC
    20 Dec 2017
    A new Project from CNIC that researches new treatments for Progeria, funded in the E-Rare 2017 call

    The project ‘Identifying new treatments for Hutchinson-Gilford progeria syndrome’ (HGPS) TREAT-HGPS, coordinated by Dr. Vicente Andrés will receive funding of 797,744 € over the next three years